Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program

The MIB-626 will be a GMP-grade microcrystalline solid NMN mixed with inert excipients (including microcrystalline cellulose) and compressed into tablets at a dose strength of 500 mg per tablet, enabling administration of the 1,000 mg twice daily using two tablets taken twice daily.

Placebo - Participants randomized to placebo will receive Matching placebo tablets will be provided by Metro International Biotech, LLC

Participants will be asked to perform high intensity, standardized, progressive, multidimensional exercise.

Participants will be asked to perform usual physical activity per listed in the protocol